# UBS Group AG: financial statements, quarterly

UBS · NYSE · CIK 1610520 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ubs.md) · [Financials](/companies/ubs/financials.md) · [Filings](/companies/ubs/filings.md) · [Insiders](/companies/ubs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ubs/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [103](/filings/0001610520-19-000031.md) | [119](/filings/0001610520-20-000041.md) | [105](/filings/0001610520-21-000035.md) | [126](/filings/0001610520-22-000028.md) | [120](/filings/0001610520-23-000052.md) | [174](/filings/0001610520-24-000041.md) | [208](/filings/0001610520-25-000023.md) | [195](/filings/0001610520-26-000023.md) | [340](/filings/0001610520-26-000023.md) | [244](/filings/0001610520-26-000023.md) | [231](/filings/0001610520-26-000023.md) |
| Total assets | $bn | not reported | [919](/filings/0001610520-19-000031.md) | [939](/filings/0001610520-20-000041.md) | [959](/filings/0001610520-21-000035.md) | [972](/filings/0001610520-22-000028.md) | [1,126](/filings/0001610520-23-000052.md) | [1,117](/filings/0001610520-24-000041.md) | [1,104](/filings/0001610520-25-000023.md) | [1,717](/filings/0001610520-26-000023.md) | [1,565](/filings/0001610520-26-000023.md) | [1,617](/filings/0001610520-26-000023.md) |
| Total liabilities | $bn | not reported | [865](/filings/0001610520-19-000031.md) | [887](/filings/0001610520-19-000031.md) | [905](/filings/0001610520-21-000035.md) | [918](/filings/0001610520-21-000035.md) | [1,066](/filings/0001610520-22-000028.md) | [1,056](/filings/0001610520-23-000052.md) | [1,047](/filings/0001610520-24-000041.md) | [1,631](/filings/0001610520-25-000023.md) | [1,479](/filings/0001610520-26-000023.md) | [1,527](/filings/0001610520-26-000023.md) |
| Shareholders' equity | $bn | not reported | [52.9](/filings/0001610520-19-000031.md) | [52.5](/filings/0001610520-19-000031.md) | [52.9](/filings/0001610520-21-000035.md) | [54.5](/filings/0001610520-21-000035.md) | [59.4](/filings/0001610520-22-000028.md) | [60.7](/filings/0001610520-23-000052.md) | [56.9](/filings/0001610520-24-000041.md) | [85.6](/filings/0001610520-25-000023.md) | [85.1](/filings/0001610520-26-000023.md) | [90.2](/filings/0001610520-26-000023.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 3,341,581,714 at 2025-12-31, from the cover of the [20-F filed 2026-03-09](/filings/0001610520-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.
